The drug has been introduced under the brand name Glempa (Empagliflozin 10/25 mg), along with its fixed-dose combinations (FDCs)Glempa-L (Empagliflozin 10/25 mg + Linagliptin 5 mg) and Glempa-M ...

(Reuters) -India’s Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France’s Amplitude Surgical for 256.8 million euros (nearly $280 million) as part of its plans to expand further ...

use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use, according to a ...

In May 2020, the Food and Drug Administration (FDA) recommended that some makers of metformin extended release remove some of their tablets from the U.S. market. This is because an unacceptable ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation, will carry out ...

The project is expected to get underway in March 2025. Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company ...

High Conviction Stocks Idea Attributes-Company: a) Sound / resilient business; b) Consistent strong financials; c) High growth potential; and d) High return on invested capital.Industry: a) Market ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In their paper, titled “Metformin-regulated glucose flux from the circulation to the intestinal lumen,” the investigators concluded, “A previously unrecognized, substantial flux of glucose ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company is ready to launch the season's first India's Flu protection as per WHO recommended composition of quadrivalent influenza virus ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

New Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has ...